Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value (VIST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B), while Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value trades at $70.49 (market cap $7.74B). The key difference: Kymera Therapeutics Inc. Common Stock and Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value are close in size by market cap, and Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value for 4 Days on average.
| KYMR | VIST | |
|---|---|---|
Market Cap | $8.88B | $7.74B |
Volume | 1,028,790 | 797,145 |
Sector | Health | Energy |
52-Week High | $127.31 | $79.25 |
52-Week Low | $55.80 | $35.02 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $8.27B | $10.88B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Vista Energy (VIST) trades at $69.02, down 0.58% on the day, with strong bullish technical signals from moving averages despite recent earnings misses. The company demonstrates robust fundamentals with 52.72% gross margins and 23.88% net income margins, supported by 32% production growth in Q2 2026. Recent news highlights Peter Thiel's $418 million investment and positive coverage from Seeking Alpha citing 70% EBITDA margins.
The outlook remains positive with 100% analyst buy ratings and $91 consensus price target representing 32% upside. Key risks include consecutive earnings misses, high debt levels, and oil price volatility. The stock offers attractive valuation at 9.08 P/E with strong operational momentum in Argentina's Vaca Muerta basin driving growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A share with no par value
Vista Energy is an independent oil and gas company focused on exploration, development, and production in Latin America. Its operations are centered on the Vaca Muerta formation in Argentina.
Read more on VIST →
